A pilot randomized trial to evaluate the efficacy of oral and nasal povidone iodine in reducing the burden of severe acute respiratory syndrome coronavirus 2 RNA in patients with coronavirus disease 2019
Infect Control Hosp Epidemiol. 2023 Apr;44(4):679-681.
doi: 10.1017/ice.2022.257.
Epub 2022 Oct 21.